|
WO2011044185A2
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
WO2011044187A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
WO2012138734A1
(en)
|
2011-04-07 |
2012-10-11 |
Merck Sharp & Dohme Corp. |
C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
US9145426B2
(en)
|
2011-04-07 |
2015-09-29 |
Merck Sharp & Dohme Corp. |
Pyrrolidine-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
|
|
KR20140054295A
(ko)
*
|
2011-08-22 |
2014-05-08 |
머크 샤프 앤드 돔 코포레이션 |
Bace 억제제로서의 2-스피로-치환된 이미노티아진 및 그의 모노- 및 디옥시드, 조성물 및 그의 용도
|
|
AU2013265376B2
(en)
*
|
2012-05-24 |
2017-07-20 |
F. Hoffmann-La Roche Ag |
5-amino[1,4]thiazines as BACE 1 inhibitors
|
|
US9556135B2
(en)
|
2012-10-12 |
2017-01-31 |
Amgen, Inc. |
Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
|
|
EP2931284B1
(en)
|
2012-12-14 |
2017-08-23 |
Merck Sharp & Dohme Corp. |
Bace inhibitors of iminothiadiazine dioxides
|
|
CA2894919A1
(en)
|
2012-12-20 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
C5,c6 oxacyclic-fused iminothiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
EP2934534B1
(en)
*
|
2012-12-21 |
2017-12-13 |
Merck Sharp & Dohme Corp. |
C5-spiro iminothiadiazine dioxides as bace inhibitors
|
|
WO2014120658A1
(en)
|
2013-01-29 |
2014-08-07 |
Amgen Inc. |
Fused multicyclic 3-amino-5,6-dihydro-2h-1,4-thiazine derivatives and their use as beta-secretase inhibitors
|
|
CA2902212C
(en)
|
2013-03-01 |
2020-10-13 |
Amgen Inc. |
Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
AU2014225604B2
(en)
|
2013-03-08 |
2018-05-17 |
Amgen Inc. |
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
EP2968353B1
(en)
*
|
2013-03-15 |
2018-12-19 |
Merck Sharp & Dohme Corp. |
C2-azaspiro iminothiazine dioxides as bace inhibitors
|
|
US9422255B2
(en)
|
2013-03-15 |
2016-08-23 |
Merck Sharp & Dohme Corp. |
S-imino-S-oxo-iminothiazine compounds as BACE inhibitors, compositions, and their use
|
|
EP2968356B1
(en)
|
2013-03-15 |
2018-03-07 |
Merck Sharp & Dohme Corp. |
S-imino-s-oxo iminothiadiazine compounds as bace inhibitors, compositions, and their use
|
|
WO2015017407A1
(en)
|
2013-07-30 |
2015-02-05 |
Amgen Inc. |
Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta- secretase
|
|
EP3083575B1
(en)
|
2013-12-18 |
2021-11-03 |
Merck Sharp & Dohme Corp. |
C-6 spirocarbocyclic iminothiadiazine dioxides as bace inhibitors, compositions, and their use
|
|
US9745324B2
(en)
|
2013-12-18 |
2017-08-29 |
Merck Sharp & Dohme Corp. |
Iminothiadiazepane dioxide compounds as BACE inhibitors, compositions, and their use
|
|
EP2918171A1
(en)
*
|
2014-03-14 |
2015-09-16 |
University of Vienna |
Novel plant growth regulators and their use in modulating organ number
|
|
CR20160455A
(es)
|
2014-04-10 |
2016-12-16 |
Pfizer |
2-AMINO-6-METIL-4,4a,5,6-TETRAHIDROPIRANO[3,4-d][1,3]TIAZIN-8a(8H)-IL-1,3-TIAZOL-4-ILA
|
|
US9732088B2
(en)
|
2014-06-02 |
2017-08-15 |
Merck Sharp & Dohme Corp. |
C2-carbocyclic iminothiazine dioxides as BACE inhibitors, compositions, and their use
|
|
EP3172206B1
(en)
*
|
2014-07-25 |
2019-01-30 |
F.Hoffmann-La Roche Ag |
Pyridyl-triazabicycles
|
|
US9957269B2
(en)
|
2014-09-12 |
2018-05-01 |
Merck Sharp & Dohme Corp. |
S-imino-S-oxo iminothiazine compounds as bace inhibitors, compositions, and their use
|
|
WO2016118404A1
(en)
|
2015-01-20 |
2016-07-28 |
Merck Sharp & Dohme Corp. |
Iminothiadiazine dioxides bearing an amine-linked substituent as bace inhibitors, compositions, and their use
|
|
AU2016236402B2
(en)
|
2015-03-20 |
2019-08-01 |
F. Hoffmann-La Roche Ag |
BACE1 inhibitors
|
|
WO2016172255A1
(en)
*
|
2015-04-21 |
2016-10-27 |
Allgenesis Biotherapeutics, Inc. |
Compounds and their use as bace1 inhibitors
|
|
WO2017024180A1
(en)
|
2015-08-06 |
2017-02-09 |
Amgen Inc. |
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
WO2017051276A1
(en)
|
2015-09-24 |
2017-03-30 |
Pfizer Inc. |
N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3] thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl] amides
|
|
JP2018531924A
(ja)
|
2015-09-24 |
2018-11-01 |
ファイザー・インク |
テトラヒドロピラノ［３，４−ｄ］［１，３］オキサジン誘導体、およびｂａｃｅ阻害剤としてのその使用
|
|
ES2928164T3
(es)
|
2015-10-19 |
2022-11-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
MD3377488T2
(ro)
|
2015-11-19 |
2023-02-28 |
Incyte Corp |
Compuși heterociclici ca imunomodulatori
|
|
WO2017095759A1
(en)
|
2015-12-04 |
2017-06-08 |
Merck Sharp & Dohme Corp. |
C5-c6-carbocyclic fused iminothiadiazine dioxides as bace inhibitors, compositions, and their use
|
|
MA44075A
(fr)
|
2015-12-17 |
2021-05-19 |
Incyte Corp |
Dérivés de n-phényl-pyridine-2-carboxamide et leur utilisation en tant que modulateurs des interactions protéine/protéine pd-1/pd-l1
|
|
MY199705A
(en)
|
2015-12-22 |
2023-11-20 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
|
WO2017192961A1
(en)
|
2016-05-06 |
2017-11-09 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
WO2017205464A1
(en)
|
2016-05-26 |
2017-11-30 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
KR102685249B1
(ko)
|
2016-06-20 |
2024-07-17 |
인사이트 코포레이션 |
면역조절제로서의 복소환식 화합물
|
|
MA45669A
(fr)
|
2016-07-14 |
2019-05-22 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
|
WO2018044783A1
(en)
|
2016-08-29 |
2018-03-08 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
CA3047285A1
(en)
|
2016-12-15 |
2018-06-21 |
Amgen Inc. |
Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of use
|
|
MA54100A
(fr)
|
2016-12-15 |
2021-10-20 |
Amgen Inc |
Dérivés de thiazine en tant qu'inhibiteurs de bêta-sécrétase et procédés d'utilisation
|
|
US10947223B2
(en)
|
2016-12-15 |
2021-03-16 |
Amgen Inc. |
Substituted oxazines as beta-secretase inhibitors
|
|
AU2017378316B2
(en)
|
2016-12-15 |
2021-04-01 |
Amgen Inc. |
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
|
|
MX387729B
(es)
|
2016-12-15 |
2025-03-18 |
Amgen Inc |
Derivados de dióxido de 1,4-tiazina y dióxido 1,2,4-tiadiazina como inhibidores de beta-secretasa y métodos de uso.
|
|
PE20191532A1
(es)
|
2016-12-22 |
2019-10-23 |
Incyte Corp |
Compuestos heterociclicos como inmunomoduladores
|
|
EP3558973B1
(en)
|
2016-12-22 |
2021-09-15 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
|
CA3047991A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Bicyclic heteroaromatic compounds as immunomodulators
|
|
WO2018119224A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Tetrahydro imidazo[4,5-c]pyridine derivatives as pd-l1 internalization inducers
|
|
EP3558989B1
(en)
|
2016-12-22 |
2021-04-14 |
Incyte Corporation |
Triazolo[1,5-a]pyridine derivatives as immunomodulators
|
|
SG11202001684PA
(en)
|
2017-10-06 |
2020-03-30 |
Forma Therapeutics Inc |
Inhibiting ubiquitin specific peptidase 30
|
|
EP3728234B1
(en)
*
|
2017-12-21 |
2025-05-14 |
F. Hoffmann-La Roche AG |
Radiolabeled compounds
|
|
WO2019178129A1
(en)
|
2018-03-13 |
2019-09-19 |
Shire Human Genetic Therapies, Inc. |
Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof
|
|
RS64055B1
(sr)
|
2018-03-30 |
2023-04-28 |
Incyte Corp |
Heterociklična jedinjenja kao imunomodulatori
|
|
US11629154B2
(en)
|
2018-04-27 |
2023-04-18 |
Shionogi & Co., Ltd. |
Tetrahydropyranooxazine derivatives having selective BACE1 inhibitory activity
|
|
MD3790877T2
(ro)
|
2018-05-11 |
2023-08-31 |
Incyte Corp |
Derivați de tetrahidro-imidazo[4,5-c]piridină în calitate de imunomodulatori PD-L1
|
|
ES2988920T3
(es)
|
2018-05-17 |
2024-11-22 |
Forma Therapeutics Inc |
Compuestos bicíclicos fusionados útiles como inhibidores de la peptidasa 30 específica de ubiquitina
|
|
CN108997328B
(zh)
*
|
2018-09-06 |
2021-06-08 |
广东东阳光药业有限公司 |
亚氨基噻二嗪二氧化物衍生物及其用途
|
|
PL3860989T3
(pl)
|
2018-10-05 |
2023-07-10 |
Forma Therapeutics, Inc. |
Sprzężone piroliny, które działają jako inhibitory proteazy 30 swoistej dla ubikwityny (usp30)
|
|
JP7665593B2
(ja)
|
2019-08-09 |
2025-04-21 |
インサイト・コーポレイション |
Ｐｄ－１／ｐｄ－ｌ１阻害剤の塩
|
|
WO2021032935A1
(en)
*
|
2019-08-21 |
2021-02-25 |
Kalvista Pharmaceuticals Limited |
Enzyme inhibitors
|
|
US11370803B2
(en)
|
2019-09-18 |
2022-06-28 |
Takeda Pharmaceutical Company Limited |
Heteroaryl plasma kallikrein inhibitors
|
|
PT4031547T
(pt)
|
2019-09-18 |
2024-08-27 |
Takeda Pharmaceuticals Co |
Inibidores de calicreína plasmática e utilizações dos mesmos
|
|
AR120109A1
(es)
|
2019-09-30 |
2022-02-02 |
Incyte Corp |
Compuestos de pirido[3,2-d]pirimidina como inmunomoduladores
|
|
PE20230407A1
(es)
|
2019-11-11 |
2023-03-07 |
Incyte Corp |
Sales y formas cristalinas de un inhibidor de pd-1/pd-l1
|
|
WO2022099075A1
(en)
|
2020-11-06 |
2022-05-12 |
Incyte Corporation |
Crystalline form of a pd-1/pd-l1 inhibitor
|
|
TW202233616A
(zh)
|
2020-11-06 |
2022-09-01 |
美商英塞特公司 |
用於製備ｐｄ－１／ｐｄ－ｌ１抑制劑以及其鹽及結晶形式之方法
|
|
WO2022099018A1
(en)
|
2020-11-06 |
2022-05-12 |
Incyte Corporation |
Process of preparing a pd-1/pd-l1 inhibitor
|
|
TW202404984A
(zh)
|
2022-04-28 |
2024-02-01 |
日商第一三共股份有限公司 |
苯并三唑化合物
|